(SIX/SFZN)
All closing conditions on the path toward
Siegfried‘s acquisition of BASF’s pha
r-
maceutical supply business have been fulfilled. T
hey
include
regulatory assurance issued by
Swissmedic that the necessary approval for the Evionnaz production site will be provided in
time for the closing.
Siegfried a ssumes that the agreements between Siegfried and BASF ( c losing) a nd the co n- nected transfer of the chemical - pharmaceutical production sites in France, Germany and Switzerland will be enforced as planned on September 30, 2015.
Help employers find you! Check out all the jobs and post your resume.
Siegfried a ssumes that the agreements between Siegfried and BASF ( c losing) a nd the co n- nected transfer of the chemical - pharmaceutical production sites in France, Germany and Switzerland will be enforced as planned on September 30, 2015.
Help employers find you! Check out all the jobs and post your resume.
